Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 1
1988 1
1989 6
1990 3
1992 3
1993 5
1994 3
1995 3
1996 5
1997 9
1998 9
1999 7
2000 17
2001 27
2002 25
2003 41
2004 47
2005 63
2006 51
2007 60
2008 79
2009 64
2010 83
2011 76
2012 89
2013 110
2014 112
2015 146
2016 153
2017 138
2018 169
2019 160
2020 156
2021 155
2022 160
2023 160
2024 85

Text availability

Article attribute

Article type

Publication date

Search Results

2,233 results

Results by year

Filters applied: . Clear all
Page 1
Esophageal cancer: Risk factors, genetic association, and treatment.
Huang FL, Yu SJ. Huang FL, et al. Asian J Surg. 2018 May;41(3):210-215. doi: 10.1016/j.asjsur.2016.10.005. Epub 2016 Dec 13. Asian J Surg. 2018. PMID: 27986415 Free article. Review.
The poor prognosis and rising incidence of esophageal cancer highlight the need for improved detection and prediction methods that are essential prior to treatment. ...Esophageal cancer is often diagnosed during its advanced stages, the main reason being the lack of …
The poor prognosis and rising incidence of esophageal cancer highlight the need for improved detection and prediction methods that ar …
MSN anti-cancer nanomedicines: chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibition.
He Q, Shi J. He Q, et al. Adv Mater. 2014 Jan 22;26(3):391-411. doi: 10.1002/adma.201303123. Epub 2013 Oct 20. Adv Mater. 2014. PMID: 24142549 Review.
In the anti-cancer war, there are three main obstacles resulting in high mortality and recurrence rate of cancers: the severe toxic side effect of anti-cancer drugs to normal tissues due to the lack of tumor-selectivity, the multi-drug resistance (MDR) to fre …
In the anti-cancer war, there are three main obstacles resulting in high mortality and recurrence rate of cancers: the severe …
Photothermally Triggered Copper Payload Release for Cuproptosis-Promoted Cancer Synergistic Therapy.
Zhou J, Yu Q, Song J, Li S, Li XL, Kang BK, Chen HY, Xu JJ. Zhou J, et al. Angew Chem Int Ed Engl. 2023 Mar 13;62(12):e202213922. doi: 10.1002/anie.202213922. Epub 2023 Feb 10. Angew Chem Int Ed Engl. 2023. PMID: 36585379
Cuproptosis is a new form of programmed cell death and exhibits enormous potential in cancer treatment. However, reducing the undesirable Cu ion release in normal tissue and maximizing the copper-induced therapeutic effect in cancer sites are two main challenges. In …
Cuproptosis is a new form of programmed cell death and exhibits enormous potential in cancer treatment. However, reducing the undesir …
Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFbeta/FN1/CD44 signaling.
Sun X, Li K, Hase M, Zha R, Feng Y, Li BY, Yokota H. Sun X, et al. Theranostics. 2022 Jan 1;12(2):929-943. doi: 10.7150/thno.66148. eCollection 2022. Theranostics. 2022. PMID: 34976221 Free PMC article.
The overexpression of Lrp5 upregulated osteopontin that enriched Hsp90ab1 (Hsp90 beta) and moesin (MSN) in Lrp5 CM. Hsp90ab1 and MSN are atypical tumor-suppressing proteins since they are multi-tasking, moonlighting proteins that promote tumorigenesis in tumor cells …
The overexpression of Lrp5 upregulated osteopontin that enriched Hsp90ab1 (Hsp90 beta) and moesin (MSN) in Lrp5 CM. Hsp90ab1 and M
Integration of Palliative Care and Oncology Nursing.
Chow K, Dahlin C. Chow K, et al. Semin Oncol Nurs. 2018 Aug;34(3):192-201. doi: 10.1016/j.soncn.2018.06.001. Epub 2018 Aug 16. Semin Oncol Nurs. 2018. PMID: 30119999 Review.
CONCLUSION: Nurses have been at the forefront of efforts to develop and implement oncology and palliative care programs. Fifty years ago a cancer diagnosis meant a poor prognosis, high symptom burden, and disease uncertainty. Current cancer care has advanced to incl …
CONCLUSION: Nurses have been at the forefront of efforts to develop and implement oncology and palliative care programs. Fifty years ago a …
Exogenous/Endogenous-Triggered Mesoporous Silica Cancer Nanomedicine.
Yang B, Chen Y, Shi J. Yang B, et al. Adv Healthc Mater. 2018 Oct;7(20):e1800268. doi: 10.1002/adhm.201800268. Epub 2018 Jun 25. Adv Healthc Mater. 2018. PMID: 29938917 Review.
Due to the well-defined morphology, specific surface area, and pore volume, mesoporous silica nanoparticle (MSN)-based theranostic platforms have provided unprecedented opportunities for the development of next-generation cancer nanomedicine. ...It is highly expecte …
Due to the well-defined morphology, specific surface area, and pore volume, mesoporous silica nanoparticle (MSN)-based theranostic pl …
Anchored multiplex PCR for targeted next-generation sequencing.
Zheng Z, Liebers M, Zhelyazkova B, Cao Y, Panditi D, Lynch KD, Chen J, Robinson HE, Shim HS, Chmielecki J, Pao W, Engelman JA, Iafrate AJ, Le LP. Zheng Z, et al. Nat Med. 2014 Dec;20(12):1479-84. doi: 10.1038/nm.3729. Epub 2014 Nov 10. Nat Med. 2014. PMID: 25384085
On the basis of our experience with performing AMP on 986 clinical FFPE samples, we show its potential as both a robust clinical assay and a powerful discovery tool, which we used to identify new therapeutically important gene fusions: ARHGEF2-NTRK1 and CHTOP-NTRK1 in glioblastom …
On the basis of our experience with performing AMP on 986 clinical FFPE samples, we show its potential as both a robust clinical assay and a …
Tuning Mesoporous Silica Nanoparticles in Novel Avenues of Cancer Therapy.
Shah S, Famta P, Bagasariya D, Charankumar K, Sikder A, Kashikar R, Kotha AK, Chougule MB, Khatri DK, Asthana A, Raghuvanshi RS, Singh SB, Srivastava S. Shah S, et al. Mol Pharm. 2022 Dec 5;19(12):4428-4452. doi: 10.1021/acs.molpharmaceut.2c00374. Epub 2022 Sep 15. Mol Pharm. 2022. PMID: 36109099 Review.
The global menace of cancer has led to an increased death toll in recent years. The constant evolution of cancer therapeutics with novel delivery systems has paved the way for translation of innovative therapeutics from bench to bedside. ...Parameters governing M
The global menace of cancer has led to an increased death toll in recent years. The constant evolution of cancer therapeutics …
Interfering MSN-NONO complex-activated CREB signaling serves as a therapeutic strategy for triple-negative breast cancer.
Qin Y, Chen W, Jiang G, Zhou L, Yang X, Li H, He X, Wang HL, Zhou YB, Huang S, Liu S. Qin Y, et al. Sci Adv. 2020 Feb 19;6(8):eaaw9960. doi: 10.1126/sciadv.aaw9960. eCollection 2020 Feb. Sci Adv. 2020. PMID: 32128390 Free PMC article.
However, little is known about the regulatory mechanisms of MSN in TNBC. We found that MSN significantly stimulated breast cancer cell proliferation and invasion in vitro and tumor growth in vivo, requiring the phosphorylation of MSN and a nucleoprotei …
However, little is known about the regulatory mechanisms of MSN in TNBC. We found that MSN significantly stimulated breast …
Mesoporous Silica Materials as an Emerging Tool for Cancer Immunotherapy.
Escriche-Navarro B, Escudero A, Lucena-Sánchez E, Sancenón F, García-Fernández A, Martínez-Máñez R. Escriche-Navarro B, et al. Adv Sci (Weinh). 2022 Sep;9(26):e2200756. doi: 10.1002/advs.202200756. Epub 2022 Jul 22. Adv Sci (Weinh). 2022. PMID: 35866466 Free PMC article. Review.
Cancer immunotherapy has emerged in the past decade as a promising strategy for treating many forms of cancer by stimulating the patient's immune system. ...This review explores the role of MSN and other nano/micro-materials as an emerging tool to enhance
Cancer immunotherapy has emerged in the past decade as a promising strategy for treating many forms of cancer by stimulating t
2,233 results